 | • レポートコード：QYR2104Z1063 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がんバイオマーカー検出のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胃がんマーカー検出、乳がんマーカー検出、結腸がんマーカー検出、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がんバイオマーカー検出の市場動向 ・企業の競争状況、市場シェア ・がんバイオマーカー検出の種類別市場規模（胃がんマーカー検出、乳がんマーカー検出、結腸がんマーカー検出、その他） ・がんバイオマーカー検出の用途別市場規模（病院、クリニック、その他） ・がんバイオマーカー検出の北米市場規模2016-2027（アメリカ、カナダ） ・がんバイオマーカー検出のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がんバイオマーカー検出のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がんバイオマーカー検出の中南米市場規模2016-2027（メキシコ、ブラジル） ・がんバイオマーカー検出の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Cancer Probe、GENO、Roche、Amoydx、Brbiotech、Fusion Cancer、Thermo Fisher、Abcodia） ・結論 |
Cancer markers refer to substances directly produced by tumor cells or induced by non-tumor cells through tumor cells.
Market Analysis and Insights: Global Cancer Biomarkers Detection Market
The global Cancer Biomarkers Detection market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Cancer Biomarkers Detection market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Cancer Biomarkers Detection market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Cancer Biomarkers Detection market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Cancer Biomarkers Detection market.
Global Cancer Biomarkers Detection Scope and Market Size
Cancer Biomarkers Detection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Biomarkers Detection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Gastric Cancer Marker Detection
Breast Cancer Marker Detection
Colon Cancer Marker Detection
Others
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Cancer Probe
GENO
Roche
Amoydx
Brbiotech
Fusion Cancer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Biomarkers Detection Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Gastric Cancer Marker Detection
1.2.3 Breast Cancer Marker Detection
1.2.4 Colon Cancer Marker Detection
1.2.5 Others
1.3 Market by Application
1.3.1 Global Cancer Biomarkers Detection Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Cancer Biomarkers Detection Market Perspective (2016-2027)
2.2 Cancer Biomarkers Detection Growth Trends by Regions
2.2.1 Cancer Biomarkers Detection Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Cancer Biomarkers Detection Historic Market Share by Regions (2016-2021)
2.2.3 Cancer Biomarkers Detection Forecasted Market Size by Regions (2022-2027)
2.3 Cancer Biomarkers Detection Industry Dynamic
2.3.1 Cancer Biomarkers Detection Market Trends
2.3.2 Cancer Biomarkers Detection Market Drivers
2.3.3 Cancer Biomarkers Detection Market Challenges
2.3.4 Cancer Biomarkers Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cancer Biomarkers Detection Players by Revenue
3.1.1 Global Top Cancer Biomarkers Detection Players by Revenue (2016-2021)
3.1.2 Global Cancer Biomarkers Detection Revenue Market Share by Players (2016-2021)
3.2 Global Cancer Biomarkers Detection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Cancer Biomarkers Detection Revenue
3.4 Global Cancer Biomarkers Detection Market Concentration Ratio
3.4.1 Global Cancer Biomarkers Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Biomarkers Detection Revenue in 2020
3.5 Cancer Biomarkers Detection Key Players Head office and Area Served
3.6 Key Players Cancer Biomarkers Detection Product Solution and Service
3.7 Date of Enter into Cancer Biomarkers Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Biomarkers Detection Breakdown Data by Type
4.1 Global Cancer Biomarkers Detection Historic Market Size by Type (2016-2021)
4.2 Global Cancer Biomarkers Detection Forecasted Market Size by Type (2022-2027)
5 Cancer Biomarkers Detection Breakdown Data by Application
5.1 Global Cancer Biomarkers Detection Historic Market Size by Application (2016-2021)
5.2 Global Cancer Biomarkers Detection Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Cancer Biomarkers Detection Market Size (2016-2027)
6.2 North America Cancer Biomarkers Detection Market Size by Type
6.2.1 North America Cancer Biomarkers Detection Market Size by Type (2016-2021)
6.2.2 North America Cancer Biomarkers Detection Market Size by Type (2022-2027)
6.2.3 North America Cancer Biomarkers Detection Market Size by Type (2016-2027)
6.3 North America Cancer Biomarkers Detection Market Size by Application
6.3.1 North America Cancer Biomarkers Detection Market Size by Application (2016-2021)
6.3.2 North America Cancer Biomarkers Detection Market Size by Application (2022-2027)
6.3.3 North America Cancer Biomarkers Detection Market Size by Application (2016-2027)
6.4 North America Cancer Biomarkers Detection Market Size by Country
6.4.1 North America Cancer Biomarkers Detection Market Size by Country (2016-2021)
6.4.2 North America Cancer Biomarkers Detection Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Cancer Biomarkers Detection Market Size (2016-2027)
7.2 Europe Cancer Biomarkers Detection Market Size by Type
7.2.1 Europe Cancer Biomarkers Detection Market Size by Type (2016-2021)
7.2.2 Europe Cancer Biomarkers Detection Market Size by Type (2022-2027)
7.2.3 Europe Cancer Biomarkers Detection Market Size by Type (2016-2027)
7.3 Europe Cancer Biomarkers Detection Market Size by Application
7.3.1 Europe Cancer Biomarkers Detection Market Size by Application (2016-2021)
7.3.2 Europe Cancer Biomarkers Detection Market Size by Application (2022-2027)
7.3.3 Europe Cancer Biomarkers Detection Market Size by Application (2016-2027)
7.4 Europe Cancer Biomarkers Detection Market Size by Country
7.4.1 Europe Cancer Biomarkers Detection Market Size by Country (2016-2021)
7.4.2 Europe Cancer Biomarkers Detection Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Cancer Biomarkers Detection Market Size (2016-2027)
8.2 Asia-Pacific Cancer Biomarkers Detection Market Size by Type
8.2.1 Asia-Pacific Cancer Biomarkers Detection Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Cancer Biomarkers Detection Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Cancer Biomarkers Detection Market Size by Type (2016-2027)
8.3 Asia-Pacific Cancer Biomarkers Detection Market Size by Application
8.3.1 Asia-Pacific Cancer Biomarkers Detection Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Cancer Biomarkers Detection Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Cancer Biomarkers Detection Market Size by Application (2016-2027)
8.4 Asia-Pacific Cancer Biomarkers Detection Market Size by Region
8.4.1 Asia-Pacific Cancer Biomarkers Detection Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Cancer Biomarkers Detection Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Cancer Biomarkers Detection Market Size (2016-2027)
9.2 Latin America Cancer Biomarkers Detection Market Size by Type
9.2.1 Latin America Cancer Biomarkers Detection Market Size by Type (2016-2021)
9.2.2 Latin America Cancer Biomarkers Detection Market Size by Type (2022-2027)
9.2.3 Latin America Cancer Biomarkers Detection Market Size by Type (2016-2027)
9.3 Latin America Cancer Biomarkers Detection Market Size by Application
9.3.1 Latin America Cancer Biomarkers Detection Market Size by Application (2016-2021)
9.3.2 Latin America Cancer Biomarkers Detection Market Size by Application (2022-2027)
9.3.3 Latin America Cancer Biomarkers Detection Market Size by Application (2016-2027)
9.4 Latin America Cancer Biomarkers Detection Market Size by Country
9.4.1 Latin America Cancer Biomarkers Detection Market Size by Country (2016-2021)
9.4.2 Latin America Cancer Biomarkers Detection Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cancer Biomarkers Detection Market Size (2016-2027)
10.2 Middle East & Africa Cancer Biomarkers Detection Market Size by Type
10.2.1 Middle East & Africa Cancer Biomarkers Detection Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Cancer Biomarkers Detection Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Cancer Biomarkers Detection Market Size by Type (2016-2027)
10.3 Middle East & Africa Cancer Biomarkers Detection Market Size by Application
10.3.1 Middle East & Africa Cancer Biomarkers Detection Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Cancer Biomarkers Detection Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Cancer Biomarkers Detection Market Size by Application (2016-2027)
10.4 Middle East & Africa Cancer Biomarkers Detection Market Size by Country
10.4.1 Middle East & Africa Cancer Biomarkers Detection Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Cancer Biomarkers Detection Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Cancer Probe
11.1.1 Cancer Probe Company Details
11.1.2 Cancer Probe Business Overview
11.1.3 Cancer Probe Cancer Biomarkers Detection Introduction
11.1.4 Cancer Probe Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.1.5 Cancer Probe Recent Development
11.2 GENO
11.2.1 GENO Company Details
11.2.2 GENO Business Overview
11.2.3 GENO Cancer Biomarkers Detection Introduction
11.2.4 GENO Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.2.5 GENO Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Cancer Biomarkers Detection Introduction
11.3.4 Roche Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.3.5 Roche Recent Development
11.4 Amoydx
11.4.1 Amoydx Company Details
11.4.2 Amoydx Business Overview
11.4.3 Amoydx Cancer Biomarkers Detection Introduction
11.4.4 Amoydx Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.4.5 Amoydx Recent Development
11.5 Brbiotech
11.5.1 Brbiotech Company Details
11.5.2 Brbiotech Business Overview
11.5.3 Brbiotech Cancer Biomarkers Detection Introduction
11.5.4 Brbiotech Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.5.5 Brbiotech Recent Development
11.6 Fusion Cancer
11.6.1 Fusion Cancer Company Details
11.6.2 Fusion Cancer Business Overview
11.6.3 Fusion Cancer Cancer Biomarkers Detection Introduction
11.6.4 Fusion Cancer Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.6.5 Fusion Cancer Recent Development
11.7 Thermo Fisher
11.7.1 Thermo Fisher Company Details
11.7.2 Thermo Fisher Business Overview
11.7.3 Thermo Fisher Cancer Biomarkers Detection Introduction
11.7.4 Thermo Fisher Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.7.5 Thermo Fisher Recent Development
11.8 Abcodia
11.8.1 Abcodia Company Details
11.8.2 Abcodia Business Overview
11.8.3 Abcodia Cancer Biomarkers Detection Introduction
11.8.4 Abcodia Revenue in Cancer Biomarkers Detection Business (2016-2021)
11.8.5 Abcodia Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Cancer Biomarkers Detection Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Gastric Cancer Marker Detection
Table 3. Key Players of Breast Cancer Marker Detection
Table 4. Key Players of Colon Cancer Marker Detection
Table 5. Key Players of Others
Table 6. Global Cancer Biomarkers Detection Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Cancer Biomarkers Detection Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Cancer Biomarkers Detection Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Cancer Biomarkers Detection Market Share by Regions (2016-2021)
Table 10. Global Cancer Biomarkers Detection Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Cancer Biomarkers Detection Market Share by Regions (2022-2027)
Table 12. Cancer Biomarkers Detection Market Trends
Table 13. Cancer Biomarkers Detection Market Drivers
Table 14. Cancer Biomarkers Detection Market Challenges
Table 15. Cancer Biomarkers Detection Market Restraints
Table 16. Global Cancer Biomarkers Detection Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Cancer Biomarkers Detection Market Share by Players (2016-2021)
Table 18. Global Top Cancer Biomarkers Detection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biomarkers Detection as of 2020)
Table 19. Ranking of Global Top Cancer Biomarkers Detection Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Cancer Biomarkers Detection Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Cancer Biomarkers Detection Product Solution and Service
Table 23. Date of Enter into Cancer Biomarkers Detection Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Cancer Biomarkers Detection Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Cancer Biomarkers Detection Revenue Market Share by Type (2016-2021)
Table 27. Global Cancer Biomarkers Detection Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Cancer Biomarkers Detection Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Cancer Biomarkers Detection Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Cancer Biomarkers Detection Revenue Market Share by Application (2016-2021)
Table 31. Global Cancer Biomarkers Detection Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Cancer Biomarkers Detection Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Cancer Biomarkers Detection Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Cancer Biomarkers Detection Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Cancer Biomarkers Detection Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Cancer Biomarkers Detection Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Cancer Biomarkers Detection Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Cancer Biomarkers Detection Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Cancer Biomarkers Detection Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Cancer Biomarkers Detection Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Cancer Biomarkers Detection Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Cancer Biomarkers Detection Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Cancer Biomarkers Detection Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Cancer Biomarkers Detection Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Cancer Biomarkers Detection Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Cancer Biomarkers Detection Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Cancer Biomarkers Detection Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Cancer Biomarkers Detection Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Cancer Biomarkers Detection Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Cancer Biomarkers Detection Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Cancer Biomarkers Detection Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Cancer Biomarkers Detection Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Cancer Biomarkers Detection Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Cancer Biomarkers Detection Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Cancer Biomarkers Detection Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Cancer Biomarkers Detection Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Cancer Biomarkers Detection Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Cancer Biomarkers Detection Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Cancer Biomarkers Detection Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Cancer Biomarkers Detection Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Cancer Biomarkers Detection Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Cancer Biomarkers Detection Market Size by Country (2022-2027) & (US$ Million)
Table 63. Cancer Probe Company Details
Table 64. Cancer Probe Business Overview
Table 65. Cancer Probe Cancer Biomarkers Detection Product
Table 66. Cancer Probe Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 67. Cancer Probe Recent Development
Table 68. GENO Company Details
Table 69. GENO Business Overview
Table 70. GENO Cancer Biomarkers Detection Product
Table 71. GENO Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 72. GENO Recent Development
Table 73. Roche Company Details
Table 74. Roche Business Overview
Table 75. Roche Cancer Biomarkers Detection Product
Table 76. Roche Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 77. Roche Recent Development
Table 78. Amoydx Company Details
Table 79. Amoydx Business Overview
Table 80. Amoydx Cancer Biomarkers Detection Product
Table 81. Amoydx Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 82. Amoydx Recent Development
Table 83. Brbiotech Company Details
Table 84. Brbiotech Business Overview
Table 85. Brbiotech Cancer Biomarkers Detection Product
Table 86. Brbiotech Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 87. Brbiotech Recent Development
Table 88. Fusion Cancer Company Details
Table 89. Fusion Cancer Business Overview
Table 90. Fusion Cancer Cancer Biomarkers Detection Product
Table 91. Fusion Cancer Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 92. Fusion Cancer Recent Development
Table 93. Thermo Fisher Company Details
Table 94. Thermo Fisher Business Overview
Table 95. Thermo Fisher Cancer Biomarkers Detection Product
Table 96. Thermo Fisher Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 97. Thermo Fisher Recent Development
Table 98. Abcodia Company Details
Table 99. Abcodia Business Overview
Table 100. Abcodia Revenue in Cancer Biomarkers Detection Business (2016-2021) & (US$ Million)
Table 101. Abcodia Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Biomarkers Detection Market Share by Type: 2020 VS 2027
Figure 2. Gastric Cancer Marker Detection Features
Figure 3. Breast Cancer Marker Detection Features
Figure 4. Colon Cancer Marker Detection Features
Figure 5. Others Features
Figure 6. Global Cancer Biomarkers Detection Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Cancer Biomarkers Detection Report Years Considered
Figure 11. Global Cancer Biomarkers Detection Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Cancer Biomarkers Detection Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Cancer Biomarkers Detection Market Share by Regions: 2020 VS 2027
Figure 14. Global Cancer Biomarkers Detection Market Share by Regions (2022-2027)
Figure 15. Global Cancer Biomarkers Detection Market Share by Players in 2020
Figure 16. Global Top Cancer Biomarkers Detection Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biomarkers Detection as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Cancer Biomarkers Detection Revenue in 2020
Figure 18. Global Cancer Biomarkers Detection Revenue Market Share by Type (2016-2021)
Figure 19. Global Cancer Biomarkers Detection Revenue Market Share by Type (2022-2027)
Figure 20. North America Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Cancer Biomarkers Detection Market Share by Type (2016-2027)
Figure 22. North America Cancer Biomarkers Detection Market Share by Application (2016-2027)
Figure 23. North America Cancer Biomarkers Detection Market Share by Country (2016-2027)
Figure 24. United States Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Cancer Biomarkers Detection Market Share by Type (2016-2027)
Figure 28. Europe Cancer Biomarkers Detection Market Share by Application (2016-2027)
Figure 29. Europe Cancer Biomarkers Detection Market Share by Country (2016-2027)
Figure 30. Germany Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Cancer Biomarkers Detection Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Cancer Biomarkers Detection Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Cancer Biomarkers Detection Market Share by Region (2016-2027)
Figure 40. China Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Cancer Biomarkers Detection Market Share by Type (2016-2027)
Figure 48. Latin America Cancer Biomarkers Detection Market Share by Application (2016-2027)
Figure 49. Latin America Cancer Biomarkers Detection Market Share by Country (2016-2027)
Figure 50. Mexico Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Cancer Biomarkers Detection Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Cancer Biomarkers Detection Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Cancer Biomarkers Detection Market Share by Country (2016-2027)
Figure 56. Turkey Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Cancer Biomarkers Detection Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Cancer Probe Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 60. GENO Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 61. Roche Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 62. Amoydx Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 63. Brbiotech Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 64. Fusion Cancer Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 65. Thermo Fisher Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 66. Abcodia Revenue Growth Rate in Cancer Biomarkers Detection Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の細胞表面マーカー検出市場規模・現状・予測（2021年-2027年） Cell surface markers are also known as cell surface antigen serves as monograms to help identify and classify cells. There is an increase in demand for the cell surface marker detection market owing to the advancements in high-throughput tools and techniques used for cytological analysis. Market Ana…- 世界のがん分子バイオマーカー市場規模・現状・予測（2021年-2027年） Cancer molecular biomarkers refer to naturally-occurring molecules or genes in living organisms, which is an indicator for the presence of cancer in the body.A biomarker is a measurable indicator of biological process, condition, or disease and can be found in the blood, tissues, or other body fluid…
- 世界のコンピュータ支援検出・診断市場規模・現状・予測（2021年-2027年） Computer Aided Detection System schemes are computer systems aiming at providing second opinions to physicians to aid in diagnoses. These systems compute outputs based on information from diverse sources, primarily from medical images captured using various methods. Computer Aided Detection System h…
- 世界のコンピューター支援検出（CAD）システム市場規模・現状・予測（2021年-2027年） Computer Aided Detection System schemes are computer systems aiming at providing second opinions to physicians to aid in diagnoses. These systems compute outputs based on information from diverse sources, primarily from medical images captured using various methods. Computer Aided Detection System h…
- 世界の結腸がん市場規模・現状・予測（2021年-2027年） Colon cancer is the cancer of large intestine which form the lower part of the digestive system. The disease usually begins with a small, benign clusters of cells known as adenomatous polyps. If left untreated, these polyps may result into colon cancer. Therefore, regular screening for polyps throug…